| Eli Lilly (Suisse) SA - Cyramza 500mg/50ml, concentré pour solution de perfusion |
| 65206 | | 02 | | Cyramza 500mg/50ml | | concentré pour solution de perfusion | | L01FG02 | | Ramucirumab | | 29.10.2015 | | |
|
| Composition |
| ramucirumabum 500 mg, histidinum, histidini hydrochloridum monohydricum, glycinum, natrii chloridum corresp. natrium 86.2 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 50 ml. |
| Packungsbestandteile |
| concentré pour solution de perfusion | | | | | | | | Active Agent | Dose |
|---|
| Ramucirumabum | 500mg / 50ml |
| | BAG: Active Agent | Dose |
|---|
| Ramucirumabum | 500 mg |
| | | | Inactive agents |
|---|
| Glycin | | Histidin Hydrochloride Monohydrate | | Histidine | | Sodium Chloride | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Durchstechflasche(n) | 1861.95 | 2041.40 | A | SL | No |
|
